- Training
- December 2026
- 2 Days
Global
€1574EUR$1,816USD£1,299GBP
€1816EUR$2,095USD£1,499GBP
- Training
- December 2026
- 2 Days
Global
€1574EUR$1,816USD£1,299GBP
€1816EUR$2,095USD£1,499GBP
- Training
- November 2026
- 2 Days
Global
€1574EUR$1,816USD£1,299GBP
€1816EUR$2,095USD£1,499GBP
- Training
- September 2026
- 2 Days
Global
€1816EUR$2,095USD£1,499GBP
- Report
- June 2026
- 135 Pages
Global
From €4351EUR$4,850USD£3,717GBP
- Report
- March 2026
- 158 Pages
Global
From €4351EUR$4,850USD£3,717GBP
- Report
- November 2025
- 150 Pages
Global
From €4351EUR$4,850USD£3,717GBP
- Report
- March 2026
- 282 Pages
United States
From €4351EUR$4,850USD£3,717GBP
- Report
- February 2026
- 150 Pages
United States
From €4351EUR$4,850USD£3,717GBP
- Report
- February 2026
- 150 Pages
United States
From €4351EUR$4,850USD£3,717GBP
- Report
- February 2026
- 190 Pages
United States
From €4351EUR$4,850USD£3,717GBP
- Report
- December 2025
- 150 Pages
United States
From €4351EUR$4,850USD£3,717GBP
- Report
- December 2025
- 150 Pages
United States
From €4351EUR$4,850USD£3,717GBP
- Report
- December 2025
- 150 Pages
United States
From €4351EUR$4,850USD£3,717GBP
- Report
- December 2025
- 150 Pages
United States
From €4351EUR$4,850USD£3,717GBP
- Training
- October 2027
- 3 Days
Europe
€1937EUR$2,235USD£1,599GBP
€2301EUR$2,654USD£1,899GBP
- Training
- April 2027
- 3 Days
Europe
€1937EUR$2,235USD£1,599GBP
€2301EUR$2,654USD£1,899GBP
- Training
- November 2026
- 3 Days
Europe
€1937EUR$2,235USD£1,599GBP
€2301EUR$2,654USD£1,899GBP
- Report
- October 2025
- 99 Pages
Middle East
From €4037EUR$4,500USD£3,449GBP
- Report
- July 2020
- 269 Pages
Global
From €3138EUR$3,497USD£2,680GBP

The Vaccine Manufacturing market is a subset of the biopharmaceutical industry, which focuses on the development and production of vaccines. Vaccines are biological products that are used to prevent and treat infectious diseases. Vaccine manufacturing involves the production of active ingredients, such as antigens, as well as the formulation and packaging of the final product. Vaccine manufacturers must adhere to strict regulatory standards to ensure the safety and efficacy of their products.
The Vaccine Manufacturing market is highly competitive, with a number of large pharmaceutical companies and biotechnology firms competing for market share. Companies in the market include Merck & Co., GlaxoSmithKline, Sanofi, Pfizer, Johnson & Johnson, and Novavax. Show Less Read more